Page 46 - Read Online

Page 18 of 22 Strassheim et al. Vessel Plus 2018;2:29 I http://dx.doi.org/10.20517/2574-1209.2018.44

139. Wei L, Zhang B, Cao W, Xing H, Yu X, Zhu D. Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell
proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia. J Recept Signal Transduct Res 2015;35:329-39.
140. Barst RJ. PDGF signaling in pulmonary arterial hypertension. J Clin Invest 2005;115:2691-4.
141. Wang Y, Bai Y, Qin L, Zhang P, Yi T, Teesdale SA, Zhao L, Pober JS, Tellides G. Interferon-gamma induces human vascular smooth
muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor
complex 1 activation. Circ Res 2007;101:560-9.
142. Little PJ. GPCR responses in vascular smooth muscle can occur predominantly through dual transactivation of kinase receptors and not
classical Galphaq protein signalling pathways. Life Sci 2013;92:951-6.
143. Dahal BK, Heuchel R, Pullamsetti SS, Wilhelm J, Ghofrani HA, Weissmann N, Seeger W, Grimminger F, Schermuly RT. Hypoxic
pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-beta. Pulm Circ 2011;1:259-68.
144. Burch ML, Getachew R, Osman N, Febbraio MA, Little PJ. Thrombin-mediated proteoglycan synthesis utilizes both protein-tyrosine
kinase and serine/threonine kinase receptor transactivation in vascular smooth muscle cells. J Biol Chem 2013;288:7410-9.
145. McKean JS, Murray F, Gibson G, Shewan DA, Tucker SJ, Nixon GF. The cAMP-producing agonist beraprost inhibits human vascular
smooth muscle cell migration via exchange protein directly activated by cAMP. Cardiovasc Res 2015;107:546-55.
146. Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kubler W, Kreuzer J. Monocyte chemoattractant protein-1 induces proliferation and
interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1.
Arterioscler Thromb Vasc Biol 2002;22:914-20.
147. Ashton AW, Cheng Y, Helisch A, Ware JA. Thromboxane A2 receptor agonists antagonize the proangiogenic effects of fibroblast growth
factor-2: role of receptor internalization, thrombospondin-1, and alpha(v)beta3. Circ Res 2004;94:735-42.
148. Gao Y, Yokota R, Tang S, Ashton AW, Ware JA. Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT
phosphorylation in endothelial cells by thromboxane A(2). Circ Res 2000;87:739-45.
149. Ashton AW, Ware JA. Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell
differentiation and migration. Circ Res 2004;95:372-9.
150. Strassheim D, Riddle SR, Burke DL, Geraci MW, Stenmark KR. Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by
reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner. J Immunol 2009;183:6981-8.
151. Ren J, Zhang Y, Cai H, Ma H, Zhao D, Zhang X, Li Z, Wang S, Wang J, Liu R, Li Y, Qian J, Wei H, Niu L, Liu Y, Xiao L, Ding M, Jiang S.
Human GPR4 and the notch signaling pathway in endothelial cell tube formation. Mol Med Rep 2016;14:1235-40.
152. Kerr BA, West XZ, Kim YW, Zhao Y, Tischenko M, Cull RM, Phares TW, Peng XD, Bernier-Latmani J, Petrova TV, Adams RH, Hay N,
Naga Prasad SV, Byzova TV. Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium. Nat
Commun 2016;7:10960.
153. Lin CH, Lilly B. Notch signaling governs phenotypic modulation of smooth muscle cells. Vascul Pharmacol 2014;63:88-96.
154. Chakravarti B, Yang J, Ahlers-Dannen KE, Luo Z, Flaherty HA, Meyerholz DK, Anderson ME, Fisher RA. Essentiality of regulator of
G protein signaling 6 and oxidized Ca(2+)/calmodulin-dependent protein kinase II in Notch signaling and cardiovascular development.
J Am Heart Assoc 2017;6.
155. Sangphech N, Osborne BA, Palaga T. Notch signaling regulates the phosphorylation of Akt and survival of lipopolysaccharide-activated
macrophages via regulator of G protein signaling 19 (RGS19). Immunobiology 2014;219:653-60.
156. Ma YX, Wu ZQ, Feng YJ, Xiao ZC, Qin XL, Ma QH. G protein coupled receptor 50 promotes self-renewal and neuronal differentiation
of embryonic neural progenitor cells through regulation of notch and wnt/beta-catenin signalings. Biochem Biophys Res Commun
2015;458:836-42.
157. Feng B, Li K, Zhong H, Ren G, Wang H, Shang Y, Bai M, Liang J, Wang X, Fan D. RhoE promotes metastasis in gastric cancer through
a mechanism dependent on enhanced expression of CXCR4. PLoS One 2013;8:e81709.
158. Collett GP, Goh XF, Linton EA, Redman CW, Sargent IL. RhoE is regulated by cyclic AMP and promotes fusion of human BeWo
choriocarcinoma cells. PLoS One 2012;7:e30453.
159. Yue X, Lin X, Yang T, Yang X, Yi X, Jiang X, Li X, Li T, Guo J, Dai Y, Shi J, Wei L, Youker KA, Torre-Amione G, Yu Y, Andrade KC,
Chang J. Rnd3/RhoE modulates hypoxia-inducible factor 1alpha/vascular endothelial growth factor signaling by stabilizing hypoxia-
inducible factor 1alpha and regulates responsive cardiac angiogenesis. Hypertension 2016;67:597-605.
160. Parker AR, Ayars AG, Altman MC, Henderson WR, Jr. Lipid mediators in aspirin-exacerbated respiratory disease. Immunol Allergy
Clin North Am 2016;36:749-63.
161. Mitchell JA, Kirkby NS. Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system. Br J Pharmacol 2018; doi:
10.1111/bph.14167.
162. Fink MP, O’Sullivan BP, Menconi MJ, Wollert PS, Wang H, Youssef ME, Fleisch JH. A novel leukotriene B4-receptor antagonist in
endotoxin shock: a prospective, controlled trial in a porcine model. Crit Care Med 1993;21:1825-37.
163. Qian J, Tian W, Jiang X, Tamosiuniene R, Sung YK, Shuffle EM, Tu AB, Valenzuela A, Jiang S, Zamanian RT, Fiorentino DF, Voelkel
NF, Peters-Golden M, Stenmark KR, Chung L, Rabinovitch M, Nicolls MR. Leukotriene B4 activates pulmonary artery adventitial
fibroblasts in pulmonary hypertension. Hypertension 2015;66:1227-39.
164. Ee MT, Kantores C, Ivanovska J, Wong MJ, Jain A, Jankov RP. Leukotriene B4 mediates macrophage influx and pulmonary
hypertension in bleomycin-induced chronic neonatal lung injury. Am J Physiol Lung Cell Mol Physiol 2016;311:L292-302.
165. Tian W, Jiang X, Tamosiuniene R, Sung YK, Qian J, Dhillon G, Gera L, Farkas L, Rabinovitch M, Zamanian RT, Inayathullah M,
Fridlib M, Rajadas J, Peters-Golden M, Voelkel NF, Nicolls MR. Blocking macrophage leukotriene b4 prevents endothelial injury and
reverses pulmonary hypertension. Sci Transl Med 2013;5:200ra117.